Name | Number of supported studies | Average coverage | |
---|---|---|---|
plasmacytoid dendritic cell | 17 studies | 29% ± 11% | |
B cell | 9 studies | 26% ± 9% | |
ciliated cell | 7 studies | 25% ± 7% | |
plasmablast | 6 studies | 39% ± 17% | |
conventional dendritic cell | 5 studies | 26% ± 10% | |
epithelial cell | 5 studies | 33% ± 11% | |
natural killer cell | 5 studies | 27% ± 6% | |
CD8-positive, alpha-beta T cell | 5 studies | 25% ± 8% | |
naive B cell | 4 studies | 17% ± 3% | |
CD4-positive, alpha-beta T cell | 4 studies | 28% ± 9% | |
hematopoietic precursor cell | 3 studies | 36% ± 15% | |
non-classical monocyte | 3 studies | 25% ± 7% | |
memory B cell | 3 studies | 23% ± 8% | |
retinal ganglion cell | 3 studies | 53% ± 24% | |
erythroblast | 3 studies | 37% ± 21% | |
germinal center B cell | 3 studies | 23% ± 5% | |
macrophage | 3 studies | 22% ± 4% | |
dendritic cell | 3 studies | 50% ± 6% |
Insufficient scRNA-seq data for expression of SNRNP25 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 100% | 2857.89 | 2641 / 2642 | 100% | 76.99 | 705 / 705 |
liver | 100% | 1053.00 | 226 / 226 | 100% | 34.85 | 405 / 406 |
adrenal gland | 100% | 1401.94 | 258 / 258 | 100% | 45.27 | 229 / 230 |
uterus | 100% | 951.28 | 170 / 170 | 100% | 62.02 | 457 / 459 |
ovary | 99% | 1121.64 | 179 / 180 | 100% | 30.86 | 429 / 430 |
kidney | 100% | 1128.63 | 89 / 89 | 99% | 38.03 | 893 / 901 |
prostate | 100% | 1208.03 | 244 / 245 | 99% | 52.20 | 499 / 502 |
bladder | 100% | 938.43 | 21 / 21 | 99% | 48.07 | 498 / 504 |
thymus | 99% | 1059.17 | 646 / 653 | 100% | 41.40 | 604 / 605 |
breast | 99% | 874.75 | 456 / 459 | 99% | 64.31 | 1111 / 1118 |
intestine | 100% | 1215.20 | 966 / 966 | 98% | 42.50 | 518 / 527 |
stomach | 100% | 1107.24 | 359 / 359 | 97% | 33.86 | 277 / 286 |
pancreas | 95% | 533.52 | 310 / 328 | 100% | 26.86 | 178 / 178 |
esophagus | 100% | 1157.07 | 1441 / 1445 | 95% | 20.47 | 173 / 183 |
skin | 94% | 784.78 | 1693 / 1809 | 100% | 50.00 | 472 / 472 |
lung | 90% | 625.69 | 521 / 578 | 99% | 44.27 | 1146 / 1155 |
eye | 0% | 0 | 0 / 0 | 100% | 33.82 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 118.93 | 29 / 29 |
muscle | 100% | 2972.03 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 1158.37 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 56.80 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 35.71 | 1 / 1 |
blood vessel | 99% | 765.62 | 1316 / 1335 | 0% | 0 | 0 / 0 |
heart | 98% | 2220.11 | 847 / 861 | 0% | 0 | 0 / 0 |
adipose | 98% | 773.18 | 1182 / 1204 | 0% | 0 | 0 / 0 |
peripheral blood | 60% | 939.32 | 555 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0000398 | Biological process | mRNA splicing, via spliceosome |
GO_0008380 | Biological process | RNA splicing |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005829 | Cellular component | cytosol |
GO_0005689 | Cellular component | U12-type spliceosomal complex |
GO_0045171 | Cellular component | intercellular bridge |
GO_0005634 | Cellular component | nucleus |
GO_0005515 | Molecular function | protein binding |
Gene name | SNRNP25 |
Protein name | U11/U12 small nuclear ribonucleoprotein 25 kDa protein (U11/U12 snRNP 25 kDa protein) (U11/U12-25K) (Minus-99 protein) Chromosome 16 open reading frame 33 (Small nuclear ribonucleoprotein U11/U12 subunit 25) Small nuclear ribonucleoprotein U11/U12 subunit 25 |
Synonyms | Z69719.2-001 Z69719.2-006 C16orf33 |
Description | |
Accessions | A0AA34QW04 B8ZZ06 Q9BV90 ENST00000710415.1 H7BYR9 ENST00000417493.1 ENST00000397876.6 ENST00000293861.8 Q4TT61 |